Director at Civeo (NYSE: CVEO) receives 3,624-share equity award

Rhea-AI Filing Summary

BLANKENSHIP C RONALD reported acquisition or exercise transactions in this Form 4 filing.

Civeo Corp director C. Ronald Blankenship received a grant of 3,624 restricted common shares as equity compensation. The award carries no purchase price and was granted under the Amended and Restated 2014 Equity Participation Plan of Civeo Corporation. According to the footnote, these restricted shares vest on the earlier of one year from May 27, 2026 or the next annual shareholders' meeting date. Following this award, Blankenship directly holds 54,446 common shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider BLANKENSHIP C RONALD

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	3,624	$0.00	--

Holdings After Transaction: Common Shares — 54,446 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Restricted shares granted: 3,624 shares Grant price per share: $0.00 per share Shares owned after grant: 54,446 shares +1 more

4 metrics

Restricted shares granted 3,624 shares Grant of restricted common shares to director

Grant price per share $0.00 per share Equity compensation award with no purchase price

Shares owned after grant 54,446 shares Director’s direct common share holdings post-transaction

Vesting reference date May 27, 2026 Shares vest earlier of one year from this date or next annual meeting

Key Terms

Restricted common share award, Amended and Restated 2014 Equity Participation Plan, annual shareholders' meeting

3 terms

Restricted common share award financial

"Restricted common share award under the Amended and Restated 2014 Equity Participation Plan"

Amended and Restated 2014 Equity Participation Plan financial

"under the Amended and Restated 2014 Equity Participation Plan of Civeo Corporation"

annual shareholders' meeting financial

"that vest on the earlier of one year from May 27, 2026 or the next annual shareholders' meeting date"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 05/27/2026 - 06:40 PM Accepted by SEC EDGAR 05/27/2026 - 06:40 PM Learn about SEC filing dates

FAQ

What insider transaction did Civeo Corp (CVEO) report in this Form 4?

Civeo Corp reported that director C. Ronald Blankenship received a grant of 3,624 restricted common shares. This was an equity compensation award, not an open-market purchase, and it increased his direct ownership to 54,446 common shares after the transaction.

Was the Civeo (CVEO) insider transaction a stock purchase or a grant?

The transaction was a grant of 3,624 restricted common shares at a price of $0.00 per share. It is classified as a grant, award, or other acquisition under the company’s equity plan, rather than a cash-funded purchase in the open market.

When do the granted Civeo (CVEO) restricted shares vest for the director?

The 3,624 restricted common shares vest on the earlier of one year from May 27, 2026 or the next annual shareholders' meeting date. This time-based vesting schedule ties the award to continued service and the company’s regular shareholder meeting cycle.

How many Civeo (CVEO) shares does the director hold after this Form 4 grant?

After receiving the 3,624-share restricted stock grant, director C. Ronald Blankenship holds 54,446 common shares directly. This figure reflects his post-transaction ownership reported in the Form 4 and includes the newly awarded restricted shares.

Under which plan were the new Civeo (CVEO) restricted shares granted?

The 3,624 restricted common shares were granted under the Amended and Restated 2014 Equity Participation Plan of Civeo Corporation. This plan is the company’s equity compensation framework used to award stock-based incentives to eligible participants, including directors.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BLANKENSHIP C RONALD

(Last) (First) (Middle)

333 CLAY STREET, SUITE 4400

(Street)

HOUSTON TEXAS 77002

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Civeo Corp [ CVEO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	05/27/2026		A		3,624(1)	A	$0	54,446	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted common share award under the Amended and Restated 2014 Equity Participation Plan of Civeo Corporation that vest on the earlier of one year from May 27, 2026 or the next annual shareholders' meeting date.

Remarks:

	/s/ Bradley J. Dodson, Attorney-In-Fact	05/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)